Provider review
Polly Review: It Claims Little, Names Its Pharmacies, and Shows No Price
Polly says less than most GLP-1 sellers, and most of what it does say holds up. Compounded semaglutide "supports metabolism, energy, and weight loss" — no percentage, no timeline, nothing that reaches for a trial result. It names two of its compounding pharmacies, states the 503A category and covers all fifty states. What it does not do is show a price. The home page promises "Transparent Pricing" above a grid of six treatments with no figure beside any of them, and the visit asks for your email before anything else. The only place a plan length appears is the refund policy.
Some links on this site are affiliate links, and we may earn a commission. How we’re paid
Visit Polly (formerly Piper)Of Polly (formerly Piper)’s 1 dated product claim documented below, 1 is consistent with the cited evidence. Comparable upfront pricing is not established here. A matching claim does not mean the compounded product was tested or FDA-approved.
Claims little and names its pharmacies — then promises transparent pricing above a grid that shows no price, and asks for your email before any figure.
Correction, August 2026
This review previously said: “Polly headlines “up to 21.5% body weight” for a compounded GLP-1 — a branded drug's best-case trial result its own disclaimer disowns.”
That was wrong. This was accurate when it was published on 14 August, and it is recorded here rather than quietly deleted because a reader who saw the page then needs to know it no longer describes the site. Between then and 26 August the company completed its move from Piper's old website to Polly's website and rebuilt the site, and the sentence went with the old build. We are not claiming credit for the change and have no evidence about why it was made.
It now says: Neither the 21.5% headline nor the disclaimer under it appears anywhere on Polly's website — checked on the home page, the rebrand notice and the terms. The claim grade on the semaglutide row moves from "overstates" to "matches", because what is there now is a description with no number in it. Two things went the other way. The disclaimer that named Mounjaro, Zepbound, Wegovy and Ozempic and said Polly's products are not substitutes for them has also gone, and nothing now tells a reader that the trial evidence belongs to the approved drugs. On the other side of the ledger, the rebuilt site names two compounding pharmacies, states the 503A category and publishes fifty-state coverage, none of which the old one did.
Worth trusting if
- You want a seller that describes its products without attaching a trial number it cannot support
- You want the pharmacy named, because Polly names Hallandale and VialsRx and states the 503A category
- You are comfortable creating an account before seeing what treatment costs
Be skeptical if
- You want to compare prices before handing over an email address, because the public pages show none
- You may want to stop mid-term, because refunds are not prorated within a billing cycle and are unavailable once the prescription has gone to the pharmacy
- You want the company's name, domain and entity to agree, which after the Piper-to-Polly move they still do not
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Compounded
Phase 3 trials
Named
None found
Provenance
Products reviewed at Polly (formerly Piper)
These evidence cards classify the treatments evaluated in this review. Confirm the exact medicine and formulation proposed for your prescription with the care team.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Semaglutide (Compounded) — Polly's public pages print no price. The treatment grid lists the product without a figure, and the visit asks for an email address on its first screen.
Evidence
Has the molecule been tested for what it is sold for?
Each row summarizes human evidence for the molecule and the use being advertised. Results apply to the product, dose, population and outcome studied; they do not establish that this provider’s preparation or program produces the same results. Compounded drugs are not FDA-approved. Evidence for one use should not be assumed to support another.
1
Products with human evidence
For the advertised use, out of 1 product reviewed here. The evidence concerns the molecule, not Polly (formerly Piper)'s service.
2
Registry records cited
Distinct ClinicalTrials.gov records cited across the reviewed products. Registration alone does not establish that a treatment works.
The comparison
What they claim, against what the trials show
Each claim below is quoted word for word from Polly (formerly Piper)’s own page. Tap a row to see the quote, the trials behind it, and why it got that verdict.
Semaglutide (Compounded)Semaglutide · Compounded (503A)Claim matches the trials
“Compounded Semaglutide. Supports metabolism, energy, and weight loss.”
Read on the Polly (formerly Piper) site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. Semaglutide 2.4 mg over 68 weeks — roughly 14.9% mean weight loss, on the approved product rather than a compounded preparation.
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. Tirzepatide over 72 weeks; roughly 20–22% mean reduction at the highest tolerated dose. Listed because Polly sells compounded tirzepatide beside this product — it is not evidence for semaglutide.
Weight loss is what STEP 1 measured, and Polly attaches no number, no timeline and no trial name to it, so the claim cannot reach past the evidence. "Energy" is the one word the trial did not measure, and it is a soft word rather than a promise. What the page leaves unsaid matters more: the trial evidence a reader arrives with belongs to the approved product, not a compounded preparation, and nothing on the site says so either way.2,1
Dispensing chain
Who actually fills your prescription
- Hallandale Pharmacy
- VialsRx
Read the full account
Polly names pharmacies and states the category: "Polly partners with licensed 503A compounding pharmacies across the United States, including pharmacies such as Hallandale Pharmacy and VialsRx. These pharmacies are overseen by State Boards of Pharmacy." State boards are the correct authority, and 503A is the correct category. Two limits on how far that gets a reader: "such as" means the list is partial rather than complete, and no address, license number or link is given for either pharmacy.
Read on the Polly (formerly Piper) site, August 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Not established in this source review
Certificate of analysis readable
A readable lot report was not verified here
Read the full testing account
No certificate of analysis, potency result or purity result is published or offered, and no pharmacy is named who could be asked for one.
Read on the Polly (formerly Piper) site, August 2026.
Licensing
Licensed to dispense, and where
Coverage
Polly answers this: "Polly facilitates access to independent licensed providers and partner pharmacies available in all 50 U.S. states. We connect you with healthcare professionals and pharmacies that are fully licensed to practice and dispense in your specific state." No exclusions are named.
Read the full licensing claim
"Independent licensed providers" facilitated through the platform, with dispensing by licensed 503A compounding pharmacies "overseen by State Boards of Pharmacy". No individual clinician is named.
Read on the Polly (formerly Piper) site, August 2026.
Regulatory
The FDA warning letter
No FDA warning letter found
We did this ourselves
What happens when you sign up with Polly (formerly Piper)
We went through Polly (formerly Piper)’s signup ourselves in August 2026: the steps, when a price first appears, and what it asks you for. We stopped at checkout, so nothing here is a prescription or a medical result.
- The home page grid lists six treatments. Press "Get started" on one.
- The visit opens on Polly's app and asks for an email address.
- "Create an account" — first name, last name, and a password of at least eight characters with an uppercase letter, a number and a symbol, plus a terms and telehealth consent box.
- This walk stopped there. We do not create password-protected accounts, so nothing past that screen was seen.
- The home page grid lists compounded semaglutide, compounded tirzepatide, sermorelin, lipotropic MIC with B12, an NAD+ spray and an NAD+ vial, with no price on any card.
- "Transparent Pricing", "Same price for every dose" and "No membership or hidden fees" are printed above that grid all the same.
- A six-month plan exists, and the only place it appears is the refund policy: "If you are on a 6-month plan and have 3 or more months remaining, cancellations are not automatically eligible for a refund."
- The terms describe an automatically renewing subscription, and the refund policy adds that partial or prorated refunds are not offered for unused time within a billing cycle, and that no refund is issued once the prescription has gone to the pharmacy.
- The old Piper domain redirects to Polly, and the footer entity is "Piper Wellness LLC d/b/a JoinPolly". Both names still matter if you are checking a license or a complaint record.
- The home page names its pharmacies — Hallandale Pharmacy and VialsRx — as licensed 503A compounders "overseen by State Boards of Pharmacy", and says the list is "such as" rather than complete.
- The visit asks for an email at its first screen and a password-protected account at its second, before a single medical question.
Polly (formerly Piper) support
Assessment
What holds up, and what does not
- Its product descriptions carry no percentage, no timeline and no borrowed trial figure.
- It names two of its compounding pharmacies, Hallandale and VialsRx, and states the category as 503A overseen by State Boards of Pharmacy, which is the correct authority.
- It says every order is prepared for an individual patient on a provider's prescription.
Show 3 more
- It publishes its state coverage: all fifty.
- The operating entity is published: Piper Wellness LLC, trading as JoinPolly.
- It says the price is the same at every dose, with no membership or hidden fees.
- No price appears on any public page. The home page promises "Transparent Pricing" above a treatment grid with no figure on it.
- The visit asks for an email at the first screen and a password-protected account at the second, before any price or medical question.
- Nothing on the site tells a reader that the trial evidence they arrive with belongs to the approved products rather than to a compounded preparation.
Show 5 more
- A six-month plan exists and appears only in the refund policy.
- Refunds are not prorated within a billing cycle, and none is available once the prescription has been sent to the pharmacy.
- The pharmacy list is "such as" rather than complete, and neither named pharmacy is given an address, a license number or a link.
- No certificate of analysis or test result is published.
- The rebrand is still half-finished: the entity is Piper Wellness LLC, the old domain redirects, and the home page carries a "Most P4opular" typo above the treatment grid.
Verdict
The bottom line
Polly's claims are modest and its pharmacy disclosure is better than most, so the questions here are about money, not evidence. Ask for the price in writing before you create an account, since the site will not show you one first, and read the refund policy before you pay: it is where the six-month plan turns up, and where you learn that unused time inside a billing cycle is not refunded. If you want a number for compounded semaglutide, bring your own — STEP 1's mean was around 14.9%, on the approved drug.
Opens Polly's website. A link is not a recommendation to take anything.
What it claims
Polly's product descriptions are short:
- Compounded semaglutide — "Supports metabolism, energy, and weight loss."
- Compounded tirzepatide — "Dual-action treatment for weight loss and blood sugar control."
- Sermorelin — "Stimulates natural growth hormone for recovery and performance."
No percentage, no timeline, no trial reference. For semaglutide that leaves nothing that reaches past STEP 1, whose mean was around 14.9% over 68 weeks on the approved drug. 2 The tirzepatide trial, SURMOUNT-1, reached roughly 20–22% at the highest dose over 72 weeks. 1 Polly quotes neither, which is better than quoting the wrong one.
What the site leaves unsaid is that those trials tested the approved products. A compounded preparation is a different article, and nothing on the site tells a reader so.
Full analysis — 4 more sections"Transparent Pricing" — and no prices · Where the plan length is · Piper, Polly, and why the name matters · What is published, and what is not
"Transparent Pricing" — and no prices
The home page leads with "Transparent Pricing, proven results", then:
"Same price for every dose. No membership or hidden fees."
Below that sits the treatment grid: compounded semaglutide, compounded tirzepatide, sermorelin, lipotropic MIC with B12, an NAD+ spray and an NAD+ vial. No card carries a price. Press "Get started" and the first screen asks for your email; the second asks you to create a password-protected account. Neither shows a figure.
"Same price for every dose" is a useful promise. It is hard to use without the price.
Where the plan length is
The one place a term appears is the refund policy:
"If you are on a 6-month plan and have 3 or more months remaining, cancellations are not automatically eligible for a refund."
So six-month plans are sold. The same policy says partial or prorated refunds are not offered for unused time within a billing cycle, and that no refund is issued once the prescription has been sent to the pharmacy; the terms describe an automatically renewing subscription. Read that page before you pay.
Piper, Polly, and why the name matters
The old Piper domain redirects to Polly, and the operating entity in the footer is Piper Wellness LLC d/b/a JoinPolly.
A company mid-rebrand is not suspicious in itself, but checking a state license, a complaint history or a regulatory record requires knowing which name to search, and the answer is still both. The rebuild is not quite finished either — the treatment grid is headed "Most P4opular".
What is published, and what is not
Polly names pharmacies:
"Polly partners with licensed 503A compounding pharmacies across the United States, including pharmacies such as Hallandale Pharmacy and VialsRx. These pharmacies are overseen by State Boards of Pharmacy."
State boards are the right authority and 503A is the right category. "Such as" means the list is partial, and neither pharmacy is given an address, a license number or a link. It also publishes its coverage — all fifty states. Still absent: any certificate of analysis, potency result or purity result.
Questions
Frequently asked questions
How much does Polly cost?
Its public pages do not say. The home page lists six treatments with no price on any of them, and the visit asks for your email and then a password-protected account before showing a figure. It does promise the same price at every dose, with no membership or hidden fees.
Is Polly the same company as Piper?
Yes. The old Join Piper site redirects to Join Polly, and the footer entity reads “Piper Wellness LLC d/b/a JoinPolly”. Both names refer to the same company, which matters if you are checking a license or complaint record — search both.
Which pharmacy compounds the medication?
Polly names two: Hallandale Pharmacy and VialsRx, described as licensed 503A compounding pharmacies overseen by State Boards of Pharmacy. The list is introduced with "such as", so it may not be complete, and neither is given an address or license number.
How much weight will I lose on Polly's semaglutide?
Polly does not say, and that is the honest position. The benchmark is STEP 1, where semaglutide 2.4 mg produced a mean loss of around 14.9% over 68 weeks — on the approved product, not a compounded preparation.
Compare
Others selling what Polly (formerly Piper) sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Ranked
The lists Polly (formerly Piper) is on
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Polly (formerly Piper)'s own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 2 sources
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine 387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine 384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.